Meet Our partners

Sahlgrenska Science Park AB selected COMAS Medical Technologies AB to join their med-tech incubator CO-AX – extensive links to Sahlgrenska University Hospital. SSP has allocated partial funding for the project

A leading medical sensor technology company in the US with global operations and contacts in national and private healthcare systems. Established a joint development agreement with Masimo for inclusion of their FDA / CE approved off-the-shelf SET O3 regional oxygen perfusion sensors in COMAS products

Worcester Polytechnical Institute in the US We have an exclusive global license in place for their unique patented cutting edge tcpO2 perfusion sensor and related patents and technologies

The Swedish national innovation funding organization has approved COMAS for a grant to help fund the development project.

Granted a funding donation in May 2025 from a grant to assist in development

The Swedish Agency for Economic and Regional Growth is a government agency under the Ministry of Climate and Enterprise. The agency works to strengthen the competitiveness and sustainable growth of companies throughout the country.

AFRY is a leading European engineering and design company driving the transition towards a sustainable and resilient society. With deep industry expertise and decades of experience, AFRY helps organizations turn necessary transformation into real progress. Through innovation and close collaboration, they transform complex challenges into new opportunities and create long-lasting, meaningful change.

Cubist is a European innovation network focused on digital health and welfare technology. Through collaboration between technology, research and users, Cubist drives the development of smart solutions that enhance quality of life, independence and participation – especially for the elderly and people with functional disabilities

The overall mission of the Wound Care Collaborative Community (WCCC) is to assure that patients and health care professionals have access to safe, effective, and high-quality medical devices and drugs to treat chronic wounds.

The WCCC will work in the pre-competitive space* to identify methods, tools, approaches and appropriate clinical evidence that will enhance understanding and improve evaluation of product safety, quality, and effectiveness.